bm-navigation: bm-t1-home-navigation-1
bm-pageheader: bm-t2-aboutus-pageheader

STAT – New York biotech debuts, targeting dormant metastatic cancer cells

STAT – New York biotech debuts, targeting dormant metastatic cancer cells

A biotech based on the frightening fact that some cancer cells spread throughout the body even before a tumor is detectable emerged from stealth mode on Thursday, announcing it had raised roughly $60 million from, among others, early-stage venture capital companies and one of biotech’s 800-pound gorillas.

Read full story by Sharon Begley here.